It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Paul Flynn, the Labour MP charged with investigating the handling of the swine flu outbreak for the Council of Europe, described it as 'a pandemic that never really was'
The report accuses the World Health Organisation of grave shortcomings in the transparency of the process that led to its warning last year. The MP said that the world relied on the WHO, but after 'crying wolf', its reputation was in jeopardy.
The report questions whether the pandemic was driven by drug companies seeking a profit. Mr Flynn said predictions of a 'plague' that would wipe out up to 7.5million people proved to be 'an exaggeration', with fewer than 20,000 deaths worldwide.
Britain braced itself for up to 65,000 deaths and signed vaccine contracts worth £540million. The actual number of deaths was fewer than 500 and the country is now desperately trying to unpick the contracts and unload millions of unused jabs.
This is a confidential pharmaceutical industry trade association dossier about the WHO Expert Working Group (EWG) on R&D Financing.
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA; "Big Pharma") gave its members 4 documents: a non-public draft report of the WHO EWG and a non-public Comparative Analysis done by the working group, the IFPMA Overview of the EWG
Comparative Analysis, and IFPMA summary slide on the EWG Draft Report.
The compilation of documents shows the influence of "Big Pharma" on the policy making decisions of the WHO, the UN body safeguarding public health. These confidential documents were obtained by the drug industry before their public release to WHO member states (scheduled to be released May 2010). The document also illustrates that the WHO expert group was highly responsive to industry lobbying — a result that public health groups had feared since early 2009, when the expert group met with the industry, but refused to meet with public health groups known to be industry critics.
The likely audience for these documents include countries, public health policy makers, civil society, industry, academia, media, patients and the general public.
We must take back control from these endlessly greedy entities.